Skip to main content

Month: February 2025

Form 8.3 – Assura PLC – Correction

FORM 8.3 Amendment – the two Rule 8.3 Disclosures published this morning for dealings on 20/02/25 and 21/02/25 together replace the Rule 8.3 Disclosure published at 16:59 on 24/02/25. Changes have been made to Sections 1(e), 2(a) and 3(a). PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION(a) Full name of discloser: Foresight Group LLP(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates:     Use a separate form for...

Continue reading

Form 8.3 – Assura PLC – Correction

FORM 8.3 Amendment – the two Rule 8.3 Disclosures published this morning for dealings on 20/02/25 and 21/02/25 together replace the Rule 8.3 Disclosure published at 16:59 on 24/02/25. Changes have been made to Sections 1(e), 2(a) and 3(a). PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION(a) Full name of discloser: Foresight Group LLP(b) Owner or controller of interests and short positions disclosed, if different from 1(a):     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates:     Use a separate form for...

Continue reading

Vallourec Fourth Quarter and Full Year 2024 Results

Meudon (France), February 27th, 2025 Vallourec, a world leader in premium tubular solutions, announces today its results for the fourth quarter 2024. The Board of Directors of Vallourec SA, meeting on February 26th 2025, approved the Group’s fourth quarter 2024 Consolidated Financial Statements. Fourth Quarter 2024 ResultsQ4 Group EBITDA of €214 million, with strong 20% EBITDA margin Full year EBITDA of €832 million, exceeding midpoint of expected range Reached €21 million net cash, achieving zero net debt target a year ahead of plan International OCTG market remains strong; US market steadily improving Q1 2025 Group EBITDA expected to range between €180 million and €215 million Expect 2025 EBITDA to improve in H2 2025 vs. H1 2025 €1.50 per share dividend to be proposed at the 2025 AGMaHIGHLIGHTS Fourth Quarter 2024 ResultsGroup...

Continue reading

Azerion publishes Interim Unaudited Financial Results Q4 2024 and Preliminary Unaudited Financial Results Full Year 2024

Key highlights Q4 FY 24Azerion key financial highlightsStrong Platform performance driving profitabilityHighlights of FY and Q4 2024 Our FY 2024 performance reflects the year long focus on efficiency and profitability driven by continued investment in the advertising platform: FY 2024 Revenues up 13% from € 486.7 million1 to € 551.2 million FY 2024 Adjusted EBITDA up 21% YoY from € 62.2 million1 to € 75.1 millionSpecifically in Q4 2024, we focused on driving synergies and eliminating redundant costs in the advertising platform: Q4 2024 Adjusted EBITDA up 14% YoY from € 26.4 million to € 30.1 million  Core segment Platform outperformed the group with Adjusted EBITDA up 15% from € 22.8 million in Q4 2023 to € 26.2 million in Q4 2024 Maintained Q4 2024 Revenues at € 168 million (-2%) while integrating and reorganising 2022...

Continue reading

Correction: Exor Press Release – ABO Pricing

Amsterdam, 27 February 2025EXOR ANNOUNCES THE SUCCESSFUL PRICING OF THE ACCELERATED BOOKBUILD OFFERING FOR APPROXIMATELY 4% OF FERRARI’S OUTSTANDING SHARESExor N.V. (“Exor”) announces the successful pricing of the previously announced accelerated bookbuild offering involving the sale of approximately 7 million common shares of Ferrari N.V. (“Ferrari”) (representing approximately 4% of the outstanding common shares of Ferrari) to institutional investors (the “Offering”) for total proceeds of €3 billion. Following completion of the transaction, Exor will remain Ferrari’s single largest shareholder with approximately 20% of the economic rights and 30% of the voting rights in Ferrari’s share capital1 and remains fully committed as a long-term shareholder of Ferrari. Moreover, in the context of the transaction, Exor has entered into a 360-day...

Continue reading

IBA Notice of Full Year 2024 Results and Conference Call

FY24 results meeting to take place as a hybrid event on Thursday, 20 March 2025 at 2:30pm CET Louvain-la-Neuve, Belgium, 27 February 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the full year 2024 on Thursday, 20 March 2025 at 7am CET. Conference Call Information IBA’s management team will host a hybrid event, including a conference call and webcast conducted in English, to present the full year results, followed by a Q&A session. The conference call will be held on Thursday, 20 March 2025 at 2:30pm CET / 1:30pm GMT / 9:30am ET / 6:30am PT as a Teams webinar and can be accessed online on this link. If you would like to join by phone only, please dial (Phone conference ID 393 230 94#) Belgium:                    ...

Continue reading

Corbion announces strong full-year results with sales growth, +25% Adjusted EBITDA improvement, and strong FCF; proposes +5% dividend increase

Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today publishes its results for the year ending 31 December 2024. Key highlights annual results 2024:Organic sales growth: +2.2%                                (Q4: +1.3%)        Volume/mix: +5.2%                                      (Q4: +2.9%) Price: -3.0%                                                 (Q4: -1.6%)Continued Operations:Sales: € 1,288.1 million                                (Q4: € 315.2 million) Adjusted EBITDA: € 175.0 million                (Q4: € 39.3 million) Operating profit: € 77.3 million                     (Q4: € 15.2 million)Free Cash Flow: € 350.1 million, € 98.3 million when excluding divestment proceeds Cash flow from operating activities increased € 18.7 million to € 184.1...

Continue reading

Unifiedpost delivers on strategic refocus and improves balance sheet strength

Press  release – Regulated information –  Inside inforrmationLa Hulpe, Belgium – February 27, 2025, 7:00 a.m. CET – [REGULATED INFORMATION] Unifiedpost Group SA (Euronext: UPG) (Unifiedpost), a leading provider of integrated business communications solutions, presents its results for FY 2024. Unifedpost has executed its strategic priorities, including portfolio rationalisation, while improving its balance sheet strength and operational efficiencies. Strategic & Operational HighlightsCompleted divestments of FitekIN/ONEA and Wholesale Identity Access Business De-risked balance sheet through partial repayment of Francisco Partners’ senior facility loan by €95m Significantly reduced net debt position by ~€ 73m at year-end Enhanced governance structure with a strengthened Board and new CEO Strategic partnerships delivering value...

Continue reading

PCI Biotech full year 2024 interim results

Oslo (Norway), 27 February 2025 – PCI Biotech (OSE: PCIB), today announces its preliminary full year 2024 results. Please find enclosed the interim report and presentation. Highlights review OperationsPCI Biotech’s 2024 development goals were to demonstrate scalability and manufacturing process benefits of the photochemical-based technology (PCL) in viral vector (AAV) manufacturing by advancing the technology into mini benchtop bioreactors, which are considered representative for commercial manufacturing. Recent mini benchtop bioreactor results indicate that PCL has the potential to release increased levels of viral vectors in the upstream AAV manufacturing process, accompanied by reduced impurity levels. This is an important milestone for PCL and we consider PCL’s scalability as demonstrated by the encouraging upstream results. These...

Continue reading

Saudi Arabia’s Ministry of Energy awards prestigious feedstock allocation for joint project between Sipchem and LyondellBasell

Award marks important milestone in feasibility study of Saudi-based world-scale steam cracker and derivatives AL KHOBAR, Kingdom of Saudi Arabia and HOUSTON, Feb. 27, 2025 (GLOBE NEWSWIRE) — Sipchem and LyondellBasell (LYB) have been awarded a feedstock allocation from the Ministry of Energy of Saudi Arabia supporting a joint feasibility study for a world-scale mixed feed cracker complex combined with a diversified derivative portfolio. Sipchem and LYB will assess the viability and optimal structure for the project, which will be advanced on a 60% (Sipchem) | 40% (LYB) ownership basis. The allocation lays the foundation for both parties to define the technical, financial and commercial configuration for the project. Construction of the joint project would result in the manufacturing of petrochemical products and derivatives to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.